Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22558097 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Condition: Sickle Cell Disease
Intervention: Other: SCD Group
2 Completed
Has Results
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Conditions: Sickle Cell Anemia;   Stroke
Intervention: Procedure: transfusion therapy

Indicates status has not been verified in more than two years